Preparation and Characterization of a Novel Chimeric Protein VEGI-CTT
in Escherichia coli
Figure 8
Effect of chimeric protein VEGI-CTT in treating CA46 human
lymphoma xenograft-bearing nude mice. Nude mice were inoculated with
CA46 human lymphoma cells, and the treatment started upon tumor
xenograft establishment in nude mice. Tumor xenograft-bearing nude
mice were injected with indicated doses of VEGI-CTT, VEGI, CTT, or
VEGI and CTT combined treatment for two weeks, and tumor volumes
were measured on alternate days. Mean values and standard deviations
are presented as tumor volumes in each group (). The experiments
were repeated with similar results.
